Rythmol SR 325 MG 12HR Extended Release Oral Capsule

Rythmol SR 325 MG 12 HR Extended Release Oral Capsule

12 HR Rythmol 325 MG Extended Release Oral Capsule

12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule [Rythmol]


Rythmol SR 425 MG 12 HR Extended Release Oral Capsule

Rythmol SR 425 MG 12HR Extended Release Oral Capsule

12 HR Rythmol 425 MG Extended Release Oral Capsule

12 HR propafenone hydrochloride 425 MG Extended Release Oral Capsule [Rythmol]


EXCEDRIN Quick Tab 500 MG / 65 MG Disintegrating Oral Tablet

Excedrin Quick Tab (APAP 500 MG / caffeine 65 MG) Disintegrating Oral Tablet

APAP 500 MG / Caffeine 65 MG Disintegrating Oral Tablet [Excedrin Quick Tab]

acetaminophen 500 MG / caffeine 65 MG Disintegrating Oral Tablet [Excedrin Quick Tab]


Stopain 6 % Topical Spray
Stopain 60 MG/ML Topical Spray
Stopain COLD 6 % Topical Spray

menthol 60 MG/ML Topical Spray [Stopain]


ColdCough PD 3 MG / 2 MG / 7.5 MG in 5 mL Oral Solution

ColdCough PD (chlorpheniramine maleate 2 MG / dihydrocodeine bitartrate 3 MG / phenylephrine hydrochloride 7.5 MG) per 5 ML Oral Solution

chlorpheniramine maleate 0.4 MG/ML / dihydrocodeine bitartrate 0.6 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution [ColdCough PD]


ovine digoxin immune fab 40 MG Injection [DigiFab]


0.8 ML Amvisc 12 MG/ML Prefilled Syringe

Amvisc 1.2 % in 0.8 mL Prefilled Syringe

Amvisc 1.2 % per 0.8 ML Prefilled Syringe

0.8 ML sodium hyaluronate 12 MG/ML Prefilled Syringe [Amvisc]


Ferrimin (iron) 150 MG Oral Tablet
Ferrimin 150 456 MG Oral Tablet

ferrous fumarate 456 MG Oral Tablet [Ferrimin 150]


zonisamide 25 MG Oral Capsule [Zonegran]


metFORMIN hydrochloride 100 MG/ML Oral Solution [Riomet]

metformin hydrochloride 100 MG/ML Oral Solution [Riomet]


Symbyax (OLANZapine 6 MG / FLUoxetine 25 MG (FLUoxetine hydrochloride 28 MG)) Oral Capsule

Symbyax (olanzapine 6 MG / fluoxetine 25 MG (fluoxetine hydrochloride 28 MG)) Oral Capsule

FLUoxetine 25 MG / OLANZapine 6 MG Oral Capsule [Symbyax]

fluoxetine 25 MG / olanzapine 6 MG Oral Capsule [Symbyax]


Symbyax (olanzapine 12 MG / fluoxetine 50 MG (fluoxetine hydrochloride 56 MG)) Oral Capsule

Symbyax (OLANZapine 12 MG / FLUoxetine 50 MG (FLUoxetine hydrochloride 56 MG)) Oral Capsule

FLUoxetine 50 MG / OLANZapine 12 MG Oral Capsule [Symbyax]

fluoxetine 50 MG / olanzapine 12 MG Oral Capsule [Symbyax]


Symbyax (OLANZapine 6 MG / FLUoxetine 50 MG (FLUoxetine hydrochloride 56 MG)) Oral Capsule

FLUoxetine 50 MG / OLANZapine 6 MG Oral Capsule [Symbyax]

fluoxetine 50 MG / olanzapine 6 MG Oral Capsule [Symbyax]

Symbyax (olanzapine 6 MG / fluoxetine 50 MG (fluoxetine hydrochloride 56 MG)) Oral Capsule


12 HR Carbatrol 100 MG Extended Release Oral Capsule

Carbatrol 100 MG 12 HR Extended Release Oral Capsule

12 HR carBAMazepine 100 MG Extended Release Oral Capsule [Carbatrol]

Carbatrol 100 MG 12HR Extended Release Oral Capsule

12 HR carbamazepine 100 MG Extended Release Oral Capsule [Carbatrol]


Alimta 100 MG Injection
PEMEtrexed 100 MG Injection [Alimta]
ALIMTA 100 MG Injection


brompheniramine / HYDROcodone / pseudoephedrine

brompheniramine / hydrocodone / pseudoephedrine


carbetapentane / diphenhydrAMINE / phenylephrine

carbetapentane / diphenhydramine / phenylephrine


carbetapentane / phenylephrine / pyrilamine


chlorpheniramine / dihydrocodeine / phenylephrine


chlorpheniramine / ibuprofen / pseudoephedrine


dichlorotetrafluoroethane / ethyl chloride Topical Product


dihydrocodeine / guaiFENesin / pseudoephedrine

dihydrocodeine / guaifenesin / pseudoephedrine


diphenhydrAMINE / HYDROcodone / phenylephrine

diphenhydramine / hydrocodone / phenylephrine


guaiFENesin / phenylephrine / pyrilamine

guaifenesin / phenylephrine / pyrilamine


The acetate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol acetate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics.


acetaminophen / caffeine Disintegrating Oral Tablet


benzoyl peroxide Topical Gel [Acne-Clear]


sulfacetamide / sulfur Medicated Liquid Soap [Avar]


sodium chloride Nasal Spray [Ayr Saline Nasal]


brompheniramine / dextromethorphan / phenylephrine Oral Solution


benzoyl peroxide 100 MG/ML Topical Lotion [Del-Aqua]


benzoyl peroxide Topical Lotion [Del-Aqua]


hydrocortisone Topical Spray [Dermtex HC]


desloratadine Disintegrating Oral Tablet


dextromethorphan / phenylephrine / pyrilamine Chewable Tablet


carbidopa / entacapone / levodopa Oral Tablet


chlorpheniramine / dihydrocodeine / phenylephrine Oral Solution


chlorpheniramine / ibuprofen / pseudoephedrine Oral Tablet


diphenhydrAMINE / phenylephrine Chewable Tablet

diphenhydramine / phenylephrine Chewable Tablet


ciprofloxacin / dexamethasone Otic Suspension [Ciprodex]


ciprofloxacin / dexamethasone Otic Suspension


benzoyl peroxide Topical Cream [Clearskin]


chlorpheniramine / dihydrocodeine / phenylephrine Oral Solution [ColdCough PD]


hydroquinone Topical Cream [EpiQuin Micro]


bisacodyl Delayed Release Oral Tablet [Ex-lax Ultra]


acetaminophen / caffeine Oral Tablet [Excedrin Tension Headache]


salicylic acid / sodium thiosulfate Topical Lotion [Exoderm]


dextromethorphan Oral Solution [Elixsure Cough]


ferrous fumarate Oral Tablet [Ferrimin 150]


ferrous fumarate Oral Tablet [Ferrocite]


polysaccharide iron complex Oral Capsule [Ferrex-150]


guaiacolsulfonate / HYDROcodone Oral Solution [Hy-KXP]

guaiacolsulfonate / hydrocodone Oral Solution [Hy-KXP]


hydroCHLOROthiazide / olmesartan Oral Tablet

hydrochlorothiazide / olmesartan Oral Tablet


hydrocortisone / lidocaine Topical Lotion


tolnaftate Topical Solution [Fungi-Guard]


calcium carbonate / simethicone Chewable Tablet [Gas-X with Maalox]


mineral oil Oral Suspension [Kondremul Plain]


calcium carbonate / simethicone Chewable Tablet [Maalox Max Quick Dissolve]


aluminum hydroxide / magnesium hydroxide / simethicone Oral Suspension [Maalox Max]


sennosides, USP Oral Tablet [Perdiem Overnight]


carbidopa / entacapone / levodopa Oral Tablet [Stalevo]


propafenone Extended Release Oral Capsule


loratadine Oral Tablet [Tavist Non-Sedating]


dilTIAZem Extended Release Oral Capsule [Taztia]

diltiazem Extended Release Oral Capsule [Taztia]


thrombin Topical Solution [Thrombin-JMI]


calcium carbonate Chewable Tablet [Titralac]


salicylic acid / sodium thiosulfate Topical Lotion [Versiclear]


moxifloxacin Ophthalmic Solution [Vigamox]


oxymetazoline Nasal Spray [Zicam Sinus Relief]


alfuzosin Extended Release Oral Tablet [UroXatral]


naltrexone hydrochloride 25 MG Oral Tablet


naltrexone hydrochloride 100 MG Oral Tablet


amphotericin B lipid complex 100 MG in 20 mL Injection

amphotericin B lipid complex 100 MG per 20 ML Injection

20 ML amphotericin B lipid complex 5 MG/ML Injection


rho(D) immune globulin, human 1500 UNT per 2 ML Prefilled Syringe

rho(D) immune globulin, human 1500 UNT in 2 ML Prefilled Syringe

2 ML Rho(D) immune globulin, human 750 UNT/ML Prefilled Syringe


norgestimate 0.18 MG / ethinyl estradiol 0.035 MG Oral Tablet

ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet


butorphanol 10 MG/ML Injectable Solution


doxycycline hyclate 75 MG Delayed Release Oral Tablet


memantine hydrochloride 20 MG Oral Tablet


cloprostenol 250 MCG per ML Injectable Solution

cloprostenol 0.25 MG/ML Injectable Solution


A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory receptors resembles blackberry.


A dietary supplement containing the levo-enantiomers of carnitine and tartrate with potential chemoprotective and antioxidant activities. L-carnitine L-tartrate increases fatty acid oxidation and reduces purine catabolism and free radical formation, which may prevent exercise fatigue, muscle weakness, chemotherapy-induced peripheral neuropathy, and hyperlipoproteinemia. L-carnitine, the biologically active form of carnitine, is a carrier molecule that transports activated long-chain fatty acids (LCFAs) from the cytosol to mitochondria where fatty acids are oxidized, resulting in ATP production. L-tartrate, a salt of tartaric acid, is a potent antioxidant.


The sodium salt of the S-isomer of omeprazole, with gastric proton pump inhibitor activity. In the acidic compartment of parietal cells, esomeprazole is protonated and converted into the active achiral sulfenamide; the active sulfenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell.


An oil rendered from the fat of the emu, Dromaius novaehollandiae. Emu oil is used for its anti-inflammatory and wound healing properties.


The trisodium salt form of zinc diethylene triamine pentaacetate (Zn-DTPA or pentetate zinc) with chelating activity. Upon administration, Zn-DTPA loses the Zn ion to form stable chelates with metal ions because DTPA has a higher affinity for heavy metal ions than for Zn ions. Specifically, this agent is able to bind to and form strong complexes with the radioactive plutonium, americium, and cerium after internal contamination. The formation of these heavy metal chelates enhances radionuclide excretion.


The sodium salt form of mycophenolic acid (MPA), with immunosuppressing activity. In vivo, the active molecule MPA reversibly inhibits inosine monophosphate dehydrogenase (IMPDH) which is needed for guanine monophosphate synthesis and stops the proliferation of B and T lymphocytes. Relative to other cell types, lypmocytes are highly dependent on salvage and de novo synthesis of guanine nucleotides, thus making these cells prone to MPA cytotoxicity.


A fabric or a narrow extruded synthetic material usually with an adhesive on one or both sides, impregnated with active and inert ingredient(s).


benzalkonium chloride 0.05 % Topical Spray


magnesium citrate 70 MG / Pot citrate 99 MG Oral Capsule

magnesium citrate 70 MG / K+ citrate 99 MG Oral Capsule

magnesium citrate 70 MG / potassium citrate 99 MG Oral Capsule


acetaminophen 500 MG / caffeine 65 MG Oral Capsule

APAP 500 MG / Caffeine 65 MG Oral Capsule


ubidecarenone 300 MG Oral Capsule
coenzyme Q10 300 MG Oral Capsule


glucosamine HCl 1.5 GM / chondroitin sulfate A 1.2 GM Oral Capsule

chondroitin sulfates 1200 MG / glucosamine hydrochloride 1500 MG Oral Capsule


methylsulfonylmethane 500 MG Oral Capsule


dipyridamole 200 MG 12HR Extended Release Oral Capsule

12 HR dipyridamole 200 MG Extended Release Oral Capsule

dipyridamole 200 MG 12 HR Extended Release Oral Capsule


12 HR hydromorphone hydrochloride 4 MG Extended Release Oral Capsule

12 HR HYDROmorphone hydrochloride 4 MG Extended Release Oral Capsule


12 HR hydromorphone hydrochloride 2 MG Extended Release Oral Capsule

12 HR HYDROmorphone hydrochloride 2 MG Extended Release Oral Capsule


12 HR hydromorphone hydrochloride 8 MG Extended Release Oral Capsule

12 HR HYDROmorphone hydrochloride 8 MG Extended Release Oral Capsule


propranolol hydrochloride 120 MG 24 HR Extended Release Oral Capsule

propranolol HCl 120 MG 24HR Extended Release Oral Capsule

24 HR propranolol hydrochloride 120 MG Extended Release Oral Capsule


propranolol hydrochloride 160 MG 24 HR Extended Release Oral Capsule

24 HR propranolol hydrochloride 160 MG Extended Release Oral Capsule

propranolol HCl 160 MG 24HR Extended Release Oral Capsule


propranolol hydrochloride 80 MG 24 HR Extended Release Oral Capsule

24 HR propranolol hydrochloride 80 MG Extended Release Oral Capsule

propranolol HCl 80 MG 24HR Extended Release Oral Capsule


24 HR trandolapril 2 MG / verapamil hydrochloride 180 MG Extended Release Oral Capsule

trandolapril 2 MG / verapamil HCl 180 MG 24HR Extended Release Oral Capsule

trandolapril 2 MG / verapamil hydrochloride 180 MG 24 HR Extended Release Oral Capsule


24 HR isosorbide mononitrate 25 MG Extended Release Oral Capsule


24 HR isosorbide mononitrate 40 MG Extended Release Oral Capsule


24 HR isosorbide mononitrate 60 MG Extended Release Oral Capsule


24 HR isosorbide mononitrate 50 MG Extended Release Oral Capsule


dextroamphetamine saccharate 6.25 MG / amphetamine aspartate 6.25 MG / dextroamphetamine sulfate 6.25 MG / amphetamine sulfate 6.25 MG 24HR Extended Release Oral Capsule

24 HR amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG Extended Release Oral Capsule

amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG 24 HR Extended Release Oral Capsule


24 HR amphetamine aspartate 1.25 MG / amphetamine sulfate 1.25 MG / dextroamphetamine saccharate 1.25 MG / dextroamphetamine sulfate 1.25 MG Extended Release Oral Capsule

dextroamphetamine saccharate 1.25 MG / amphetamine aspartate 1.25 MG / dextroamphetamine sulfate 1.25 MG / amphetamine sulfate 1.25 MG 24HR Extended Release Oral Capsule

amphetamine aspartate 1.25 MG / amphetamine sulfate 1.25 MG / dextroamphetamine saccharate 1.25 MG / dextroamphetamine sulfate 1.25 MG 24 HR Extended Release Oral Capsule


24 HR diclofenac sodium 100 MG Extended Release Oral Capsule


24 HR diclofenac sodium 75 MG Extended Release Oral Capsule


diclofenac sodium 25 MG Delayed Release Oral Capsule


diclofenac sodium 50 MG Delayed Release Oral Capsule


hepatitis B immune globulin 50 UNT/ML Injectable Solution


pheniramine 22.8 MG/ML Injectable Solution


scopolamine 20 MG/ML Injectable Solution


nitrogen (inactive) 80 % / oxygen 20 % Gas for Inhalation


carbon dioxide 7 % / oxygen 93 % Gas for Inhalation


triclosan 0.5 % Foaming Medicated Hand Soap


triclosan 7.5 MG/ML Medicated Liquid Soap


chloroxylenol 10 MG/ML Medicated Liquid Soap


chloroxylenol 3 % Medicated Liquid Soap
chloroxylenol 3 % Foaming Hand Cleaner

chloroxylenol 30 MG/ML Medicated Liquid Soap


chloroxylenol 3 MG/ML Medicated Liquid Soap

chloroxylenol 0.3 % Medicated Liquid Soap


chloroxylenol 0.6 % Medicated Liquid Soap

chloroxylenol 6 MG/ML Medicated Liquid Soap


pentetate calcium trisodium 1 GM per 5 ML Injection

pentetate calcium trisodium 1 GM in 5 ML Injection

5 ML pentetate calcium trisodium 200 MG/ML Injection


sodium bicarbonate 1.26 % Injectable Solution

sodium bicarbonate 150 mEq in 1000 mL Injectable Solution

sodium bicarbonate 12.6 MG/ML Injectable Solution

sodium bicarbonate 150 mEq per 1000 ML Injectable Solution

sodium bicarbonate 0.15 MEQ/ML Injectable Solution


sorbitol (as iron sorbitol) 50 MG/ML Injectable Solution


phenylbutazone 200 MG/ML Injectable Solution


meglumine antimoniate 300 MG/ML Injectable Solution


ePHEDrine sulfate 10 MG/ML Injectable Solution

ephedrine sulfate 10 MG/ML Injectable Solution


interferon beta-1a 0.044 MG per 0.5 ML Prefilled Syringe

interferon beta-1a 44 MCG per 0.5 ML Prefilled Syringe

interferon beta-1a 44 MCG in 0.5 ML Prefilled Syringe

0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe


bevacizumab 400 MG per 16 ML Injection
bevacizumab 400 MG in 16 ML Injection


bupivacaine hydrochloride 0.375 % / lidocaine hydrochloride 1 % Injectable Solution

bupivacaine hydrochloride 3.75 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution


ampicillin (as ampicillin sodium) 500 MG Injection


terbinafine (as terbinafine hydrochloride) 0.01 MG/MG Topical Gel


meropenem (as meropenem trihydrate) 500 MG Injection


sulfacetamide sodium 0.1 MG/MG Topical Gel


vancomycin (as vancomycin hydrochloride) 750 MG Injection


vancomycin 1 GM Injection
vancomycin 1000 MG Injection

vancomycin (as vancomycin HCl) 1 GM Injection


crude coal tar 1.25 % (coal tar solution 6.25 % ) Topical Gel


camphor 0.002 MG/MG / menthol 0.035 MG/MG Topical Gel

camphor 0.2 % / menthol 3.5 % Topical Gel


ferric sulfate 20 % Dental Gel
ferric sulfate 20 % Oral Gel


miconazole nitrate 2 % / fluprednidene 0.1 % Topical Cream

fluprednidene 0.1 % / miconazole nitrate 2 % Topical Cream

fluprednidene 1 MG/ML / miconazole nitrate 20 MG/ML Topical Cream


fentaNYL (as fentaNYL citrate) 4 MCG/ML / ropivacaine hydrochloride 0.2 % Injectable Solution

fentanyl (as fentanyl citrate) 4 MCG/ML / ropivacaine hydrochloride 0.2 % Injectable Solution

fentanyl 4 MCG/ML / ropivacaine hydrochloride 0.2 % Injectable Solution

fentaNYL 0.004 MG/ML / ropivacaine hydrochloride 2 MG/ML Injectable Solution

fentaNYL 4 MCG/ML / ropivacaine hydrochloride 0.2 % Injectable Solution

fentanyl 0.004 MG/ML / ropivacaine hydrochloride 2 MG/ML Injectable Solution


ZNO 0.2 MG/MG Paste
zinc oxide 20 % Topical Paste


zinc oxide 21 % Topical Cream
ZNO 210 MG/ML Topical Cream


sodium fluoride 0.24 % (fluoride ion 0.14 % ) Toothpaste

sodium fluoride 0.24 % (fluoride ion 0.15 % ) Toothpaste

sodium fluoride 0.24 % (fluoride ion 0.13 % ) Toothpaste


stannous fluoride 0.454 % (fluoride ion 0.14 % ) Toothpaste

stannous fluoride 0.454 % (fluoride ion 0.15 % ) Toothpaste

stannous fluoride 0.454 % (fluoride ion 0.16 % ) Toothpaste

stannous fluoride 0.00454 MG/MG Toothpaste


testosterone 30 MG Buccal Film, Mucoadhesive


aluminum hydroxide 0.275 % Topical Ointment

aluminum hydroxide 0.00275 MG/MG Topical Ointment


zinc oxide 20 % Topical Cream
ZNO 200 MG/ML Topical Cream


sulfacetamide sodium 100 MG/ML Topical Cream


benzalkonium chloride 0.13 % / lidocaine 4 % Topical Cream

benzalkonium chloride 1.3 MG/ML / lidocaine 40 MG/ML Topical Cream


zinc oxide 12 % Topical Cream
ZNO 120 MG/ML Topical Cream


bacitracin 400 UNT / hydrocortisone 1 % / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment

bacitracin 400 UNT / hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment

bacitracin 0.4 UNT/MG / hydrocortisone 0.01 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment


clotrimazole 0.01 MG/MG Topical Ointment


miconazole nitrate 0.25 % / zinc oxide 15 % Topical Ointment

Miconazole Nitrate 0.0025 MG/MG / ZNO 0.15 MG/MG Topical Ointment

miconazole nitrate 0.0025 MG/MG / zinc oxide 0.15 MG/MG Topical Ointment


zinc oxide 30 % Topical Ointment
ZNO 0.3 MG/MG Topical Ointment


cefixime 200 MG per 5 ML Oral Suspension


didanosine 10 MG per 1 ML (final concentration) Powder for Oral Solution

didanosine 10 MG in 1 mL (final concentration) Powder for Oral Solution

didanosine 10 MG/ML Powder for Oral Solution


sulfacetamide sodium 10 % / sulfur 5 % Topical Cleanser

sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid Soap

sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid Soap


benzoyl peroxide 9 % Medicated Liquid Soap

benzoyl peroxide 90 MG/ML Medicated Liquid Soap


salicylic acid 0.6 % Medicated Liquid Soap

salicylic acid 6 MG/ML Medicated Liquid Soap


benzoyl peroxide 2.5 % Medicated Shampoo

benzoyl peroxide 25 MG/ML Medicated Shampoo


glycerin 82.5 % Pediatric Rectal Suppository

glycerin 1.2 GM Pediatric Rectal Suppository


codeine phosphate 1 MG/mL / chlorpheniramine maleate 0.2 MG/mL Oral Suspension

chlorpheniramine maleate 0.2 MG / codeine phosphate 1 MG per 1 ML Oral Suspension

chlorpheniramine maleate 0.2 MG/ML / codeine phosphate 1 MG/ML Oral Suspension


acetaminophen 167 MG / HYDROcodone bitartrate 2.5 MG per 5 ML Elixir

APAP 33.3 MG/ML / HYDROcodone Bitartrate 0.5 MG/ML Oral Solution

acetaminophen 33.3 MG/ML / HYDROcodone bitartrate 0.5 MG/ML Oral Solution

acetaminophen 167 MG / hydrocodone bitartrate 2.5 MG per 5 ML Elixir

APAP 33.3 MG/ML / Hydrocodone Bitartrate 0.5 MG/ML Oral Solution

acetaminophen 500 MG / HYDROcodone bitartrate 7.5 MG per 15 ML Elixir

HYDROcodone bitartrate 7.5 MG / acetaminophen 500 MG in 15 mL Oral Solution

acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution

acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG per 15 ML Elixir


bismuth subsalicylate 87 MG per 5 ML Oral Suspension

bismuth subsalicylate 87 MG in 5 mL Oral Suspension

bismuth subsalicylate 17.4 MG/ML Oral Suspension


promethazine hydrochloride 25 MG per 5 ML Oral Syrup

promethazine hydrochloride 5 MG/ML Oral Solution


midazolam (as midazolam hydrochloride) 10 MG per 5 ML Syrup

midazolam (as midazolam hydrochloride) 2 MG/ML Syrup


Pot gluconate 312 MG/ML Oral Solution
K+ gluconate 312 MG/ML Oral Solution

potassium gluconate 312 MG/ML Oral Solution


diazePAM 10 MG per 2.5 mL Enema
diazepam 10 MG per 2.5 ML Enema
diazePAM 4 MG/ML Enema
diazePAM 10 MG per 2.5 ML Enema


diazepam 5 MG per 2.5 ML Enema
diazePAM 5 MG per 2.5 mL Enema
diazePAM 5 MG per 2.5 ML Enema
diazePAM 2 MG/ML Enema


erythromycin (as erythromycin ethylsuccinate) 100 MG/ML Oral Suspension


clobetasol propionate 0.05 % Medicated Shampoo

clobetasol propionate 0.5 MG/ML Medicated Shampoo


piroctone olamine 0.5 % Medicated Shampoo

piroctone olamine 5 MG/ML Medicated Shampoo


calcium carbonate 1500 MG (calcium 600 MG) / vitamin D3 10 MCG (400 UNT) Oral Tablet

calcium carbonate 1500 MG / cholecalciferol 400 UNT Oral Tablet

calcium carbonate 1500 MG / cholecalciferol 0.01 MG Oral Tablet

calcium 600 MG / vitamin D3 10 MCG (400 UNT) Oral Tablet, as calcium carbonate


calcium carbonate 625 MG / magnesium oxide 155 MG Oral Tablet


calcium 167 MG Oral Tablet, as calcium acetate

calcium acetate 668 MG (calcium 169 MG) Oral Tablet


glucosamine HCl 500 MG / chondroitin sulfates 400 MG Oral Tablet

chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Tablet


chondroitin sulfates 600 MG / glucosamine HCl 750 MG Oral Tablet

chondroitin sulfates 600 MG / glucosamine hydrochloride 750 MG Oral Tablet


prednisoLONE 20 MG Oral Tablet
prednisoLONE acetate 20 MG Oral Tablet


pilocarpine hydrochloride 7.5 MG Oral Tablet


HCTZ 12.5 MG Oral Tablet
hydroCHLOROthiazide 12.5 MG Oral Tablet


alpha-D-galactosidase enzyme 150 UNT Oral Tablet


K+ Iodide 65 MG Oral Tablet
Pot Iodide 65 MG Oral Tablet
potassium iodide 65 MG Oral Tablet


Pot gluconate 99 MG Oral Tablet
K+ gluconate 99 MG Oral Tablet
potassium gluconate 99 MG Oral Tablet


ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet

ethinyl estradiol 2.5 MCG / norethindrone acetate 500 MCG Oral Tablet

norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet


calcium glycerophosphate 65 MG Oral Tablet


glucosamine HCl 500 MG / methylsulfonylmethane 167 MG / chondroitin sulfate A 400 MG Oral Tablet

chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG / methylsulfonylmethane 167 MG Oral Tablet


thrombin, bovine 2000 UNT/ML Topical Solution

thrombin, bovine 2000 UNT in 1 mL Topical Solution

thrombin, bovine 2000 UNT per 1 ML Topical Solution


dextromethorphan hydrobromide 10 MG Oral Lozenge


Bumetanide 0.5 MG / Pot Chloride 573 MG Extended Release Oral Tablet

Bumetanide 0.5 MG / K+ Chloride 573 MG Extended Release Oral Tablet

bumetanide 0.5 MG / potassium chloride 573 MG Extended Release Oral Tablet


traMADol hydrochloride 150 MG 12 HR Extended Release Oral Tablet

tramadol hydrochloride 150 MG 12 HR Extended Release Oral Tablet

12 HR traMADol hydrochloride 150 MG Extended Release Oral Tablet

12 HR tramadol hydrochloride 150 MG Extended Release Oral Tablet


terbutaline sulfate 7.5 MG 12HR Extended Release Oral Tablet

12 HR terbutaline sulfate 7.5 MG Extended Release Oral Tablet


Bendroflumethiazide 2.5 MG / K+ Chloride 630 MG Extended Release Oral Tablet

Bendroflumethiazide 2.5 MG / Pot Chloride 630 MG Extended Release Oral Tablet

bendroflumethiazide 2.5 MG / potassium chloride 630 MG Extended Release Oral Tablet


bendroflumethiazide 2.5 MG / potassium chloride 573 MG Extended Release Oral Tablet

Bendroflumethiazide 2.5 MG / K+ Chloride 573 MG Extended Release Oral Tablet

Bendroflumethiazide 2.5 MG / Pot Chloride 573 MG Extended Release Oral Tablet


prazosin 5 MG Extended Release Oral Tablet


cinacalcet 90 MG (as cinacalcet HCl 99 MG) Oral Tablet


cinacalcet 60 MG (as cinacalcet HCl 66 MG) Oral Tablet


cinacalcet 30 MG (as cinacalcet HCl 33 MG) Oral Tablet


oxyCODONE hydrochloride 20 MG Oral Tablet

oxycodone hydrochloride 20 MG Oral Tablet


acetaminophen 250 MG / aspirin 250 MG Oral Tablet


dihydrocodeine bitartrate 10 MG Oral Tablet


ASA 300 MG Chewable Tablet
aspirin 300 MG Chewable Tablet


norethindrone 0.4 MG / ethinyl estradiol 35 MCG Chewable Tablet

ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet


esomeprazole 20 MG (as esomeprazole magnesium 22.3 MG) Delayed Release Oral Tablet

esomeprazole magnesium 20 MG Delayed Release Oral Tablet

esomeprazole 20 MG Delayed Release Oral Tablet


esomeprazole 40 MG Delayed Release Oral Tablet


24 HR alprazolam 0.5 MG Extended Release Oral Tablet

ALPRAZolam 0.5 MG 24 HR Extended Release Oral Tablet

ALPRAZolam 0.5 MG 24HR Extended Release Oral Tablet

alprazolam 0.5 MG 24 HR Extended Release Oral Tablet

24 HR ALPRAZolam 0.5 MG Extended Release Oral Tablet


24 HR alprazolam 2 MG Extended Release Oral Tablet

ALPRAZolam 2 MG 24HR Extended Release Oral Tablet

24 HR ALPRAZolam 2 MG Extended Release Oral Tablet

ALPRAZolam 2 MG 24 HR Extended Release Oral Tablet

alprazolam 2 MG 24 HR Extended Release Oral Tablet


ALPRAZolam 1 MG 24 HR Extended Release Oral Tablet

24 HR ALPRAZolam 1 MG Extended Release Oral Tablet

24 HR alprazolam 1 MG Extended Release Oral Tablet

alprazolam 1 MG 24 HR Extended Release Oral Tablet

ALPRAZolam 1 MG 24HR Extended Release Oral Tablet


ALPRAZolam 3 MG 24HR Extended Release Oral Tablet

24 HR ALPRAZolam 3 MG Extended Release Oral Tablet

24 HR alprazolam 3 MG Extended Release Oral Tablet

ALPRAZolam 3 MG 24 HR Extended Release Oral Tablet

alprazolam 3 MG 24 HR Extended Release Oral Tablet


indapamide 1.5 MG 24HR Extended Release Oral Tablet

indapamide 1.5 MG 24 HR Extended Release Oral Tablet

24 HR indapamide 1.5 MG Extended Release Oral Tablet


naproxen sodium 500 MG 24HR Extended Release Oral Tablet

naproxen 500 MG (naproxen sodium 550 MG) 24 HR Extended Release Oral Tablet

24 HR naproxen 500 MG Extended Release Oral Tablet


lovastatin 20 MG 24HR Extended Release Oral Tablet

24 HR lovastatin 20 MG Extended Release Oral Tablet


bezafibrate 400 MG 24 HR Extended Release Oral Tablet

bezafibrate 400 MG 24HR Extended Release Oral Tablet

24 HR bezafibrate 400 MG Extended Release Oral Tablet


gliclazide 30 MG 24HR Extended Release Oral Tablet

gliclazide 30 MG 24 HR Extended Release Oral Tablet

24 HR gliclazide 30 MG Extended Release Oral Tablet


24 HR isosorbide mononitrate 25 MG Extended Release Oral Tablet


hydroxychloroquine sulfate 400 MG Oral Tablet


24 HR isosorbide mononitrate 40 MG Extended Release Oral Tablet


24 HR isosorbide mononitrate 50 MG Extended Release Oral Tablet


traMADol hydrochloride 300 MG 24 HR Extended Release Oral Tablet

24 HR tramadol hydrochloride 300 MG Extended Release Oral Tablet

tramadol hydrochloride 300 MG 24 HR Extended Release Oral Tablet

traMADol HCl 300 MG 24HR Extended Release Oral Tablet

24 HR traMADol hydrochloride 300 MG Extended Release Oral Tablet


24 HR traMADol hydrochloride 200 MG Extended Release Oral Tablet

traMADol HCl 200 MG 24 HR Extended Release Oral Tablet

24 HR tramadol hydrochloride 200 MG Extended Release Oral Tablet

traMADol HCl 200 MG 24HR Extended Release Oral Tablet

tramadol HCl 200 MG 24 HR Extended Release Oral Tablet


doxycycline hyclate 100 MG Delayed Release Oral Tablet


cholecalciferol 10 MCG (400 UNT) Oral Capsule

vitamin D3 10 MCG (400 UNT) Oral Capsule


sodium iodide 200 MG/ML Injectable Solution


diphenhydramine HCl 1.667 MG/ML Oral Solution

diphenhydrAMINE hydrochloride 1.67 MG/ML Oral Solution

diphenhydrAMINE HCl 50 MG in 30 mL Oral Solution

diphenhydramine HCl 50 MG per 30 ML Oral Solution

diphenhydrAMINE HCl 1.667 MG/ML Oral Solution

diphenhydrAMINE HCl 50 MG per 30 ML Oral Solution

diphenhydramine hydrochloride 1.67 MG/ML Oral Solution


dexamethasone 2 MG per 1 ML Injectable Solution

dexamethasone 2 MG in 1 ML Injectable Solution

dexamethasone 2 MG/ML Injectable Solution


The sodium salt of bemiparin, a second generation, synthetic, low-molecular-weight heparin (LMWH) with anticoagulant activity. Derived, after depolymerisation and fractionation, from medical-grade porcine unfractionated heparin (UFH), bemiparin has an average molecular weight of 3,600 daltons and has a higher anti-factor Xa/anti-factor IIa ratio (8:1) than first-generation LMWHs. This anticoagulant binds to antithrombin III, thereby enhancing the inactivation of activated factor X (Factor Xa) and, to a lesser extent, activated factor II (Factor IIa). Compared to unfractionated heparins, the use of bemiparin is associated with lower incidences of major bleeding, osteoporosis, and heparin-induced thrombocytopenia. Bemiparin also promotes a greater release of tissue factor pathway inhibitor than UFH or dalteparin.


The mesylate salt form of paroxetine, a phenylpiperidine derivative and a selective serotonin reuptake inhibitor (SSRI) with antidepressant and anxiolytic properties. Paroxetine binds to the pre-synaptic serotonin transporter complex resulting in negative allosteric modulation of the complex, thereby blocking reuptake of serotonin by the pre-synaptic transporter. Inhibition of serotonin recycling enhances serotonergic function through serotonin accumulation in the synaptic cleft, which resulting in long-term desensitization and downregulation of 5HT1 (serotonin) receptors and leading to symptomatic relief of depressive illness.


The oil extracted from the seeds of Apium graveolens. Celery seed oil is used to treat disorders of the digestive system.


chloroxylenol 0.5 % Medicated Liquid Soap

chloroxylenol 5 MG/ML Medicated Liquid Soap


levothyroxine sodium 12.5 MCG Oral Tablet

levothyroxine sodium 0.0125 MG Oral Tablet


ZNO 50 MG/ML Topical Cream
zinc oxide 5 % Topical Cream


A methylene-substituted bisphosphonate. Medronic acid has affinity for and adheres to the surface of hydroxyapatite crystals in the bone matrix. This agent accumulates at sites of osteoid mineralization and can be used, complexed with radioisotopes such as technetium 99m, in bone imaging.


The essential oil of Salvia sclarea. Clary sage oil is used in the treatment of depression, stress, insomnia and deep seated tension.


bupivacaine / lidocaine Injectable Solution


alpha-D-galactosidase enzyme Oral Tablet


bendroflumethiazide / potassium chloride Extended Release Oral Tablet


A recombinant human immunoglobulin (Ig) G1 monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.


bumetanide / potassium chloride Extended Release Oral Tablet


carBAMazepine Extended Release Oral Tablet

carbamazepine Extended Release Oral Tablet


chlorpheniramine / codeine Oral Suspension


esomeprazole Delayed Release Oral Tablet


estrogens, conjugated (USP) / norgestrel Oral Tablet


fenofibrate Delayed Release Oral Capsule


folic acid 0.1 MG Oral Tablet
folic acid 100 MCG Oral Tablet


chondroitin sulfates / glucosamine Oral Tablet


hepatitis B immune globulin Injectable Solution


benzyl alcohol / lidocaine Topical Cream


magnesium chloride Delayed Release Oral Tablet


A human plasma-derived immunoglobulin G (IgG) formulation containing high levels of antibodies against varicella zoster virus (VZV), a double-stranded DNA virus that causes chickenpox and herpes zoster (shingles), with potential immunomodulating and antiviral activities. VZV IgG (VARIZIG) is isolated from donors expressing high amounts of VZV antibodies. Upon intramuscular (IM) administration, the anti-VZV antibodies provide passive immunization against VZV. This may prevent infection by VZV in immunocompromised patients.

varicella zoster immune globulin (human)


aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack

{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack


{21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Apri 28 Day]


0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe

darbepoetin alfa 200 MCG per 0.4 ML Prefilled Syringe

darbepoetin alfa 0.2 MG per 0.4 ML Prefilled Syringe

darbepoetin alfa 200 MCG in 0.4 ML Prefilled Syringe


ibandronic acid 2.5 MG (as ibandronate sodium 2.81 MG) Oral Tablet


0.5 ML interferon beta-1a 0.06 MG/ML Prefilled Syringe [Avonex]

Avonex 30 MCG in 0.5 ML Prefilled Syringe

Avonex 30 MCG per 0.5 ML Prefilled Syringe

Avonex 0.03 MG per 0.5 ML Prefilled Syringe


leuprolide acetate 7.5 MG in 1 ML (1 month) Prefilled Syringe

1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe

leuprolide acetate 7.5 MG per 1 ML (1 month) Prefilled Syringe


{7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Necon 7/7/7 28 Day]


calcium carbonate / monofluorophosphate Oral Tablet


magnesium citrate / potassium citrate Oral Capsule


meglumine antimoniate Injectable Solution


capsaicin / methylnicotinate Topical Cream


fluprednidene / miconazole Topical Cream


miconazole / zinc oxide Topical Ointment


ethinyl estradiol / norethindrone Chewable Tablet


acetaminophen / phenylephrine Oral Capsule


acetaminophen / chlorpheniramine / phenylephrine Chewable Tablet


dexchlorpheniramine / HYDROcodone / phenylephrine Oral Solution

dexchlorpheniramine / hydrocodone / phenylephrine Oral Solution


sulfADIAZINE / trimethoprim Oral Suspension

sulfadiazine / trimethoprim Oral Suspension


The hydrochloride salt of chloroquine, a synthetic quinoline with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.


sulfacetamide / sulfur Medicated Liquid Soap


venlafaxine Extended Release Oral Capsule


dextroamphetamine saccharate 5 MG / amphetamine aspartate 5 MG / dextroamphetamine sulfate 5 MG / amphetamine sulfate 5 MG Oral Tablet

amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet

mixed amphetamine salts 20 MG Oral Tablet


acetaminophen / butalbital / caffeine Oral Solution


dextromethorphan / phenylephrine Chewable Tablet


A starch derived from corn grain and used as food or food ingredient, with potential anti-hypoglycemic activity. Upon ingestion, corn starch is broken down and releases glucose in the gastrointestinal (GI) tract. Glucose is taken up in the bloodstream and maintains as well as stabilizes glucose levels. This may prevent or improve hypoglycemia in patients with glycogen storage disease or insulinomas.


The trisodium salt form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic resonance angiography (MRA) imaging. Gadofosveset is a stable gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) chelate derivative with a diphenylcyclohexylphosphate group. Upon injection, gadofosveset binds reversibly to endogenous serum albumin which increases its intravascular retention time compared to non-protein binding contrast agents. The serum albumin binding also increases T1-relaxivity of gadofosveset. This produces an increase in signal intensity of blood, thereby enhancing the visualization of blood vessels upon MRA and may aid in the diagnosis of certain blood vessels and heart disorders.


A humanized monoclonal antibody against CD4, with anti-human immunodeficiency virus (HIV) activity. Ibalizumab binds to CD4, the primary receptor for HIV, thereby inhibiting HIV entry into CD4-positive T-cells. This leads to a reduction in viral load.


A human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication.


A peptide-drug conjugate composed of a peptide conjugated, via an aminopeptidase-targeting linkage, to the alkylating agent melphalan, with potential antineoplastic and anti-angiogenic activities. Upon administration, the highly lipophilic melphalan flufenamide penetrates cell membranes and enters cells. In aminopeptidase-positive tumor cells, melphalan flufenamide is hydrolyzed by peptidases to release the hydrophilic alkylating agent melphalan. This results in the specific release and accumulation of melphalan in aminopeptidase-positive tumor cells. Melphalan alkylates DNA at the N7 position of guanine residues and induces DNA intra- and inter-strand cross-linkages. This results in the inhibition of DNA and RNA synthesis and the induction of apoptosis, thereby inhibiting tumor cell proliferation. Peptidases are overexpressed by certain cancer cells. The administration of melphalan flufenamide allows for enhanced efficacy and reduced toxicity compared to melphalan.


A nonbenzodiazepine, cyclopyrrolone and active stereoisomer of zopiclone with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, eszopiclone is able to bind to and activate the omega-1 subtype of the alpha subunit of the gamma-aminobutyric acid-benzodiazepine GABA receptor complex (GABA-A), a chloride ionophore complex in the central nervous system (CNS). This leads to the opening of chloride channels, causing hyperpolarization, inhibition of neuronal firing, and enhancement of the inhibitory effect of GABA. This eventually leads to a hypnotic effect and allows for an induction of sleep.


A preparation of naturally occurring, oncolytic enterovirus, with potential antineoplastic activity. Upon administration, coxsackievirus V937 targets and binds to intracellular adhesion molecule 1 (ICAM-1) and decay acceleration factor (DAF), both cell surface molecules that are overexpressed on certain malignant cells. After entering the cells, coxsackievirus V937 replicates in these cancer cells, thereby causing cancer cell lysis. This results in a reduction of tumor cell growth.


bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment [Spectrocin Plus]


chlorproMAZINE hydrochloride 20 MG/ML Oral Solution

chlorpromazine hydrochloride 20 MG/ML Oral Solution


A sterile solution containing culture filtrate of various Trichophyton species. It is used to test for delayed hypersensitivity to the fungus.


desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet


urokinase 5000 UNT/ML Injectable Solution


voriconazole 40 MG per 1 ML Oral Suspension

voriconazole 200 MG/5 ML Oral Suspension

voriconazole 40 MG in 1 mL Oral Suspension


acetylcysteine 6 GM per 30 ML Injection
acetylcysteine 6 GM in 30 ML Injection

30 ML acetylcysteine 200 MG/ML Injection


estradiol 0.1 MG per 24 HR Vaginal System, 90 Day

estradiol acetate 0.1 MG per 24HR 3 Month Vaginal System

90 DAY estradiol 0.00417 MG/HR Vaginal System


baclofen 10 MG Disintegrating Oral Tablet


baclofen 20 MG Disintegrating Oral Tablet


estrogens, conjugated 0.3 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet

estrogens, conjugated (USP) 0.3 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet

estrogens, conjugated (USP) 0.3 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet


estrogens, conjugated 0.45 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet

estrogens, conjugated (USP) 0.45 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet

estrogens, conjugated (USP) 0.45 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet


hyaluronic acid 20 MG/ML Injectable Solution


metFORMIN hydrochloride 625 MG Oral Tablet

metformin hydrochloride 625 MG Oral Tablet


methylphenidate hydrochloride 2.5 MG Oral Tablet


pyridostigmine bromide 30 MG Oral Tablet


APAP 500 MG / clemastine fumarate 0.335 MG / phenylpropanolamine hydrochloride 30 MG Oral Tablet

acetaminophen 500 MG / clemastine fumarate 0.335 MG / phenylpropanolamine HCl 30 MG Oral Tablet

acetaminophen 500 MG / clemastine fumarate 0.335 MG / phenylpropanolamine hydrochloride 30 MG Oral Tablet


fluorometholone acetate 0.1 % / tobramycin 0.3 % Ophthalmic Drops

tobramycin 0.3 % / fluorometholone acetate 0.1 % Ophthalmic Drops

fluorometholone acetate 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension


oxymetazoline hydrochloride 0.05 % Ophthalmic Solution

oxymetazoline HCl 0.05 % Ophthalmic Solution

oxymetazoline hydrochloride 0.5 MG/ML Ophthalmic Solution


Phenazopyridine hydrochloride 200 MG / SMX 800 MG / TMP 160 MG Oral Tablet

phenazopyridine HCl 200 MG / sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet

phenazopyridine hydrochloride 200 MG / sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet


ibandronic acid 50 MG (as ibandronate sodium 56.3 MG) Oral Tablet


bemiparin sodium 6750 UNT per 0.3 ML Prefilled Syringe

0.3 ML bemiparin sodium 22500 UNT/ML Prefilled Syringe


bemiparin sodium 16,000 UNT per 0.4 ML Prefilled Syringe

0.4 ML bemiparin sodium 40000 UNT/ML Prefilled Syringe


parakeet feather allergenic extract
budgerigar feather allergenic extract

Melopsittacus undulatus feather allergenic extract


Aspergillus fumigatus allergenic extract


Cladosporium herbarum allergenic extract


EPINEPHrine 0.1 % / lidocaine HCl 10 % Iontophoretic Medicated Patch

epinephrine 0.1 % / lidocaine HCl 10 % Iontophoretic Medicated Patch

EPINEPHrine 0.001 MG/MG / lidocaine hydrochloride 0.1 MG/MG Medicated Patch

epinephrine 0.001 MG/MG / lidocaine hydrochloride 0.1 MG/MG Medicated Patch


chlorpheniramine / dextromethorphan / pseudoephedrine


brompheniramine / dextromethorphan / phenylpropanolamine


A combination preparation of glucosamine, a hexosamine sugar polymer, and methyl sulfonyl methane (MSM), a derivative of dimethyl sulphoxide, with anti-arthritic and anti-inflammatory activities. The mechanism of action has not yet been fully elucidated but addition of glucosamine to chondrocytes results in inhibition of proteoglycan catabolism. Glucosamine inhibits interleukin-1-induced production of inflammatory mediators (nitric oxide, prostaglandin E2), and inhibit aggrecanase activity, which results in preservation of proteoglycan and chondrocytes. Other studies have also shown glucosamine to reduce the generation of reactive oxygen species by macrophages, and inhibit lysosomal enzymes. MSM has been suggested to exert its analgesic effect by inhibiting pain impulses along type C nerve fibers, reducing inflammation and muscle spasms, as well as promoting blood flow, thereby promoting the healing of cartilage lesions.


chlorpheniramine / codeine / phenylephrine / potassium iodide


carbetapentane / chlorpheniramine / ePHEDrine / phenylephrine

carbetapentane / chlorpheniramine / ephedrine / phenylephrine


chlorpheniramine / HYDROcodone / pseudoephedrine

chlorpheniramine / hydrocodone / pseudoephedrine


acetaminophen / dexbrompheniramine / pseudoephedrine


acetaminophen / dextromethorphan / doxylamine / pseudoephedrine


chlorpheniramine / guaiFENesin / HYDROcodone / pseudoephedrine

chlorpheniramine / guaifenesin / hydrocodone / pseudoephedrine


bacitracin / neomycin / polymyxin B / pramoxine


nitrofurantoin, macrocrystals / nitrofurantoin, monohydrate


insulin analog, glulisine 100 UNT/ML Injectable Solution

insulin glulisine 100 UNT/ML Injectable Solution

insulin glulisine, human 100 UNT/ML Injectable Solution


penicillin G benzathine / penicillin G procaine


guaiFENesin / phenylephrine / phenylpropanolamine

guaifenesin / phenylephrine / phenylpropanolamine

A combination preparation containing phenylephrine, phenylpropanolamine and guaifenesin with decongestant and expectorant activities. Phenylephrine and phenylpropanolamine, direct-acting sympathicomimetic amines, activate alpha-adrenergic receptors in the nasal mucosa thereby causing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion. Phenylpropanolamine also releases norepinephrine from its storage sites resulting in the effects already described. Guaifenesin increases respiratory tract mucus secretions and reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus, thereby increasing the efficiency of removing accumulated secretions from the upper and lower airways and making cough more productive.


dextromethorphan / guaiFENesin / phenylpropanolamine

dextromethorphan / guaifenesin / phenylpropanolamine


acetaminophen / dextromethorphan / diphenhydrAMINE / pseudoephedrine

acetaminophen / dextromethorphan / diphenhydramine / pseudoephedrine


chlorpheniramine / codeine / pseudoephedrine


acetaminophen / dextromethorphan / pseudoephedrine


The oil extracted from the seeds of Cucurbita pepo var. styriaca. Pumpkin seed oil is used primarily as a food flavoring.


A commercial combination preparation by Novartis containing acetaminophen, aspirin, and caffeine with analgesic activity. Acetaminophen exerts antipyretic and analgesic activities by inhibiting prostaglandin synthesis while aspirin, a salicylate, inhibits cyclooxygenases (COX) with anti-inflammatory, antipyretic and analgesic properties. Caffeine is a central nervous system stimulant and causes constriction of dilated cerebral blood vessels. Excedrin is used for the relief and treatment of migraine and tension headaches.


aluminum hydroxide / magnesium hydroxide / simethicone


fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe

0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe

fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe


fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe

fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe

0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe


fondaparinux sodium 10 MG per 0.8 ML Prefilled Syringe

fondaparinux sodium 10 MG in 0.8 ML Prefilled Syringe

0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe


A formulated therapeutic oral agent consisting of a combination of the 5-fluorouracil (5-FU) congener prodrug tegafur (tetrahydrofuranyl-5-fluorouracil) and uracil (1:4). The high concentration of uracil reversibly inhibits the uracil-reducing enzyme dihydropyrimidine dehydrogenase (DPD), thereby inhibiting first-pass DPD-mediated hepatic metabolism of the uracil analogue 5-FU and permitting administration of 5-FU as the orally bioavailable prodrug tegafur. Tegafur is bioactivated to 5-FU by liver microsomal cytochrome P450 enzymes. 5-FU is subsequently converted into its active metabolites 5-fluoro-deoxyuridine-monophosphate (FdUMP) and 5-fluorouridine-triphosphate (FUTP) intracellularly; these metabolites inhibit the enzyme thymidylate synthase and intercalate into RNA, resulting in decreased thymidine synthesis, reduced DNA synthesis, disrupted RNA function, and tumor cell cytotoxicity.


A recombinant protein that inactivates the ribosome with potential antineoplastic and immunomodulating activities. Aviscumine binds to the cell surface sialyltransferase CD75 and is internalized; intracellularly, aviscumine cleaves an adenine-specific N-glycosidic bond on the 28S ribosomal subunit, which may result in tumor cell apoptosis. This agent has also been shown to activate natural killer (NK) cells, induce cytokine receptor expression, and stimulate the release of cytokines. CD75 is expressed on mature B-cells and subsets of T-cells and erythrocytes.


The succinate salt form of tafenoquine, an orally bioavailable 8-aminoquinoline derivative, with antimalarial activity. Although the mechanism is not completely understood, upon administration, tafenoquine inhibits the parasitic enzyme heme polymerase in the blood stages of the parasites. This inhibits the conversion of the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Tafenoquine is active against all the stages of Plasmodium species and is also active against the pre-erythrocytic liver stages of the parasites. This prevents the development of the erythrocytic forms of the parasite which are responsible for relapses in P. vivax malaria.


A synthetic thymidine nucleoside analogue with antiviral activity highly specific for the treatment of hepatitis B virus (HBV). Intracellularly, telbivudine is phosphorylated to its active metabolite, telbivudine triphosphate. The dideoxy telbivudine triphosphate competes with thymidine for incorporation into viral DNA, thereby causing DNA chain termination and inhibiting the function of HBV DNA polymerase (reverse transcriptase). This results in the blockade of HBV DNA replication and viral propagation.


An orally bioavailable vitamin E derivative with potential antineoplastic and immunostimulating activities. Upon administration, alpha-tocopheryloxyacetic acid (alpha-TEA) induces tumor autophagy; the autophagosomes formed, which carry tumor associated antigens (TAAs), allow for increased cross-presentation of TAAs by professional antigen-presenting cells (APCs). This activates a T cell-mediated T helper type 1 (TH1) response, generates a cytotoxic T-lymphocyte (CTL) response against cancer cells, and reduces the frequency of regulatory T-cell (Treg) differentiation. In addition, alpha-TEA modulates the release of various cytokines and chemokines and induces tumor cell apoptosis. Altogether, this results in decreased tumor cell proliferation.


A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the anterior pituitary, thereby reducing secretion of luteinizing hormone (LH) by pituitary gonadotroph cells and so decreasing testosterone production by interstitial (Leydig) cells in the testes.


An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.


primaquine phosphate 26.3 MG Oral Tablet

primaquine phosphate 26.3 MG (primaquine 15 MG) Oral Tablet


A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis.


A diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.


The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.


The hydrochloride salt of duloxetine, a fluoxetine derivative belonging to the class of selective serotonin (5-HT) and norepinephrine (NE) reuptake inhibitors (SSNRIs) and exhibiting antidepressant activity. Duloxetine selectively prevents the reuptake of 5-HT and NE via transporter complexes on the pre-synaptic membrane, thereby increasing the level of these neurotransmitters within the synaptic cleft. As a result, this agent potentiates serotonergic and noradrenergic activities in the central nervous system, and alleviates depression and neuropathy sensations, such as pain and tingling. Furthermore, duloxetine does not show significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and gamma-aminobutyric acid (GABA) receptors.


A synthetic, orally-active quinazoline with potential antineoplastic properties. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.


A synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone.


An orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.


A solution intended for use as a vaginal irrigant.


benzethonium chloride 0.13 % Topical Foam

benzethonium chloride 1.3 MG/ML Topical Foam


cloZAPine 100 MG Disintegrating Oral Tablet

clozapine 100 MG Disintegrating Oral Tablet


cloZAPine 25 MG Disintegrating Oral Tablet

clozapine 25 MG Disintegrating Oral Tablet


duloxetine 20 MG (as duloxetine HCl 22.4 MG) Delayed Release Oral Capsule

DULoxetine 20 MG Delayed Release Oral Capsule

DULoxetine 20 MG (as DULoxetine HCl 22.4 MG) Delayed Release Oral Capsule

duloxetine 20 MG Delayed Release Oral Capsule


A recombinant form of the naturally-occurring polypeptide human epidermal growth factor with potential epithelial regenerative and cytoprotective activities. Upon topical application, recombinant human epidermal growth factor (rhEGF) may stimulate epithelial proliferation, differentiation and migration, which may result in the acceleration of epithelial regeneration and wound healing. In addition, rhEGF may attenuate epithelial cytotoxicities related to chemotherapy and/or radiotherapy.


amiodarone hydrochloride 300 MG Oral Tablet


cetirizine hydrochloride 10 MG Chewable Tablet


cetirizine hydrochloride 5 MG Chewable Tablet


calcium carbonate 1177 MG (calcium 470 MG) Chewable Tablet

calcium carbonate 1177 MG (Ca 470 MG) Chewable Tablet

calcium carbonate 1177 MG Chewable Tablet


ezetimibe 10 MG / simvastatin 10 MG Oral Tablet


ezetimibe 10 MG / simvastatin 20 MG Oral Tablet


ezetimibe 10 MG / simvastatin 40 MG Oral Tablet


ezetimibe 10 MG / simvastatin 80 MG Oral Tablet


mesalamine 500 MG Extended Release Oral Capsule


methylphenidate HCl 10 MG per 5 ML Oral Solution

methylphenidate HCl 10 MG in 5 mL Oral Solution

methylphenidate hydrochloride 10 MG per 5 ML Oral Solution

methylphenidate hydrochloride 2 MG/ML Oral Solution


methylphenidate HCl 10 MG Chewable Tablet

methylphenidate hydrochloride 10 MG Chewable Tablet


Carbidopa 25 MG / L-DOPA 100 MG Disintegrating Oral Tablet

carbidopa 25 MG / levodopa 100 MG Disintegrating Oral Tablet


dextromethorphan HBr 15 MG / guaiFENesin 25 MG in 5 mL Oral Solution

dextromethorphan HBr 15 MG / guaifenesin 25 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 3 MG/ML / guaiFENesin 5 MG/ML Oral Solution

dextromethorphan HBr 15 MG / guaiFENesin 25 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 3 MG/ML / guaifenesin 5 MG/ML Oral Solution


Carbidopa 25 MG / L-DOPA 250 MG Disintegrating Oral Tablet

carbidopa 25 MG / levodopa 250 MG Disintegrating Oral Tablet


dextromethorphan HBr 0.3 MG/ML Oral Solution

dextromethorphan hydrobromide 0.3 MG/ML Oral Solution


estradiol 14 MCG/Day Weekly Transdermal System

estradiol 14 MCG/Day Weekly Transdermal Patch

estradiol 0.000583 MG/HR Weekly Transdermal Patch

168 HR estradiol 0.000583 MG/HR Transdermal System


calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet

calcium carbonate 675 MG / milk of magnesia 135 MG Chewable Tablet

calcium carbonate 675 MG / magnesium hydroxide 135 MG Chewable Tablet


calcium carbonate 675 MG / milk of magnesia 135 MG / simethicone 60 MG Chewable Tablet

calcium carbonate 675 MG / magnesium hydroxide 135 MG / simethicone 60 MG Chewable Tablet


cefdinir 250 MG per 5 ML Oral Suspension


A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.


vitamin B 12 500 MCG / folic acid 1 MG Oral Tablet

folate 1 MG / vitamin B12 0.5 MG Oral Tablet

cyanocobalamin 0.5 MG / folic acid 1 MG Oral Tablet

folic acid 1 MG / vitamin B12 0.5 MG Oral Tablet


acetaminophen 300 MG / HYDROcodone bitartrate 10 MG Oral Tablet

APAP 300 MG / hydrocodone bitartrate 10 MG Oral Tablet

HYDROcodone bitartrate 10 MG / acetaminophen 300 MG Oral Tablet

APAP 300 MG / HYDROcodone bitartrate 10 MG Oral Tablet

acetaminophen 300 MG / hydrocodone bitartrate 10 MG Oral Tablet


hydroxypropylcellulose 5 MG Ophthalmic Insert

hydroxypropylcellulose 5 MG Ophthalmic Drug Implant

hydroxypropylcellulose 5 MG Drug Implant


iron succinyl milk protein complex 800 MG per 15 ML (iron 40 MG per 15 ML) Oral Solution

iron succinyl milk protein complex (as iron) 40 MG in 15 mL Oral Solution

iron succinyl milk protein complex (as iron) 40 MG per 15 ML Oral Solution

iron succinyl milk protein complex 53.3 MG/ML Oral Solution


An orally available magnesium salt of glycine. Magnesium activates over 600 enzymes and is essential for DNA and RNA synthesis, cellular repair, and maintaining the antioxidant status of the cell. Magnesium plays a key role in bone and muscle function and assists in the activation of vitamin D, which helps regulate calcium and phosphate homeostasis to influence the growth and maintenance of bones.


methylphenidate hydrochloride 5 MG per 5 ML Oral Solution

methylphenidate HCl 5 MG in 5 mL Oral Solution

methylphenidate HCl 5 MG per 5 ML Oral Solution

methylphenidate HCl 10 MG per 10 ML Oral Solution

methylphenidate hydrochloride 1 MG/ML Oral Solution


glucosamine sulfate 750 MG / chondroitin sulfate A sodium 600 MG Oral Tablet

chondroitin sulfate A sodium 600 MG / glucosamine sulfate 750 MG Oral Tablet


hydrocortisone acetate 2 % / pramoxine HCl 1 % Topical Gel

hydrocortisone acetate 2 % / pramoxine hydrochloride 1 % Topical Gel

hydrocortisone acetate 0.02 MG/MG / pramoxine hydrochloride 0.01 MG/MG Topical Gel


nizatidine 75 MG in 5 mL Oral Solution
nizatidine 75 MG per 5 ML Oral Solution


HYDROcodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet

hydrocodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet


12 HR guaifenesin 900 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet

guaifenesin 900 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet

guaiFENesin 900 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet

12 HR guaiFENesin 900 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet

guaiFENesin 900 MG / phenylephrine HCl 25 MG 12HR Extended Release Oral Tablet


A deciduous shrub or small tree in the family Lythraceae, order Myrtales, superorder Rosanae. It bears edible reddish-purple fruit berries with seeds and pulp produced from the ovary of a single flower.


chlorpheniramine maleate 2 MG per 1 ML Oral Solution

chlorpheniramine maleate 2 MG in 1 mL Oral Solution

chlorpheniramine maleate 2 MG/ML Oral Solution


A polyethylene glycol derivative of hydrogenated castor oil where the average PEG chain length is 35. PEG-35 hydrogenated castor oil is a nonionic surfactant used as an emulsifying and solubilising agent in pharmaceutical preparations and cosmetics.


HCTZ 25 MG / telmisartan 80 MG Oral Tablet

hydroCHLOROthiazide 25 MG / telmisartan 80 MG Oral Tablet

telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet

hydrochlorothiazide 25 MG / telmisartan 80 MG Oral Tablet


zinc oxide 16 % Topical Paste
ZNO 0.16 MG/MG Paste


ZNO 306 MG/ML Topical Cream
zinc oxide 30.6 % Topical Cream


An herbal supplement used commonly to alleviate symptoms of benign prostatic hyperplasia. In vitro studies show that it may also have anti-cancer properties specific for prostate cancer.


sulfonated phenol 50 % / sulfuric acid 30 % Mucous Membrane Topical Solution

sulfonated phenol 500 MG/ML / sulfuric acid 300 MG/ML Mucous Membrane Topical Solution


cyanocobalamin 2 MG / folic acid 2.5 MG / pyridoxine HCl 25 MG Oral Tablet

folic acid 2.5 MG / vitamin B6 25 MG / vitamin B 12 2 MG Oral Tablet

folate 2.5 MG / vitamin B12 2 MG / vitamin B6 25 MG Oral Tablet

folic acid 2.5 MG / vitamin B12 2 MG / vitamin B6 25 MG Oral Tablet


dextromethorphan hydrobromide 4 MG/ML / guaiFENesin 20 MG/ML / pseudoephedrine hydrochloride 10 MG/ML Oral Solution

dextromethorphan hydrobromide 4 MG/ML / guaifenesin 20 MG/ML / pseudoephedrine hydrochloride 10 MG/ML Oral Solution


lansoprazole 6 MG/ML Injectable Solution


A hydrogenated derivative of soybean oil. Hydrogenated soybean oil has a thicker consistency than standard soybean oil and is used as a food ingredient and is found in skincare products.


carbidopa / levodopa Disintegrating Oral Tablet


iron succinyl milk protein complex Oral Solution


brompheniramine / phenylephrine Oral Suspension


chlorpheniramine / dextromethorphan / phenylephrine Oral Tablet


diphenhydrAMINE Disintegrating Oral Tablet

diphenhydramine Disintegrating Oral Tablet


methylphenidate HCl 5 MG Chewable Tablet

methylphenidate hydrochloride 5 MG Chewable Tablet


A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.


Chlorzoxazone Acetaminophen is a combination of muscle relaxant (Chlorzoxazone) and anti-inflammatory analgesic (Acetaminophen) indicated in acute painful musculoskeletal diseases. The active principal metabolite of phenacetin, Acetaminophen appears to inhibit prostaglandin biosynthesis in the central nervous system and less in peripheral tissues. With mild sedative properties, centrally acting Chlorzoxazone inhibits muscle spasm at the spinal cord and subcortical levels of the brain. (NCI04)


A combination preparation of the nonsteroidal anti-inflammatory drug salicylic acid and the inorganic compound sulfur with keratolytic activity. Salicylic acid and sulfur loosen and shed dead cells, thereby preventing skin pores from clogging up. This combination treats acne, dandruff and several other skin and scalp disorders.


A liposomal formulation of Vincristine designed to reduce toxicity and improve efficacy. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI)


A liposome-encapsulated preparation of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin. Doxorubicin intercalates between DNA base pairs, thereby hinders the movement of replication machinery along DNA strands, as well as blocks the activity of topoisomerase II during replication. As a result, this agent causes DNA adducts formation, renders single- and double-stranded DNA breakages that induce DNA repair and or apoptotic processes. Doxorubicin also generates reactive oxygen species that leads to cytotoxicity secondary to lipid peroxidation of cell membrane lipids. Liposomal delivery of doxorubicin HCl improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects. A liposomal formulation of doxorubicin also modulates toxicity, specifically the cardiac effects commonly seen with anthracycline antitumor drugs.


A synthetic microsphere formulation with arterial occlusive properties. Amilomer, a product produced by partially hydrolyzing starch and epichlorohydrin, contains degradable starch microspheres (DSM) with a diameter size of 45 micrometers that are readily degraded by amylase. When used in transcatheter arterial chemoembolization (TACE) procedures, infusion leads to lodging of the microspheres in the precapillary vessels and, consequently, to the occlusion of the hepatic artery. Local occlusion of selected blood vessels in conjunction with intrahepatic chemotherapy administration, results in elevated intracellular hepatocyte drug concentrations and enhances localized cytotoxicity against hepatic tumor lesions.


A bicyclic depsipeptide antibiotic isolated from the bacterium Chromobacterium violaceum with antineoplastic activity. After intracellular activation, romidepsin binds to and inhibits histone deacetylase (HDAC), resulting in alterations in gene expression and the induction of cell differentiation, cell cycle arrest, and apoptosis. This agent also inhibits hypoxia-induced angiogenesis and depletes several heat shock protein 90 (Hsp90)-dependent oncoproteins.


A selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities. Vilazodone inhibits the reuptake of serotonin from the synaptic cleft while stimulating the release of 5-HT into the synaptic cleft. This increases the concentration of 5-HT in the synaptic cleft and potentiates serotonergic neurotransmission in the central nervous system.


A 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti-angiogenic activity. Pegaptanib binds and blocks the activity of the extracellular vascular endothelial growth factor, specifically the 165-amino acid isoform (VEGF165). This prevents VEGF165 from binding to VEGF receptors, thereby blocking angiogenesis as well as preventing VEGF165-induced increases in vessel permeability. VEGF165 is preferentially involved in pathological ocular neovascularisation.


chlorothiazide (as chlorothiazide sodium) 0.5 GM Injection


darbepoetin alfa 500 MCG per 1 ML Prefilled Syringe

darbepoetin alfa 500 MCG in 1 ML Prefilled Syringe

darbepoetin alfa 0.5 MG per 1 ML Prefilled Syringe

1 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe


dehydroepiandrosterone 10 MG Oral Tablet


acetaminophen 1000 MG in 100 ML Injection

acetaminophen 1000 MG per 100 ML Injection


carbidopa 10 MG / levodopa 100 MG Disintegrating Oral Tablet

Carbidopa 10 MG / L-DOPA 100 MG Disintegrating Oral Tablet


sodium hyaluronate 12 MG/mL in 0.5 mL Prefilled Syringe

sodium hyaluronate 6 MG per 0.5 ML Prefilled Syringe

0.5 ML sodium hyaluronate 12 MG/ML Prefilled Syringe


sodium hyaluronate 8 MG per 0.5 ML Prefilled Syringe

sodium hyaluronate 16 MG/mL in 0.5 mL Prefilled Syringe

0.5 ML sodium hyaluronate 16 MG/ML Prefilled Syringe


sodium hyaluronate 7.7 MG per 0.55 ML Prefilled Syringe

sodium hyaluronate 14 MG/mL in 0.55 mL Prefilled Syringe

0.55 ML sodium hyaluronate 14 MG/ML Prefilled Syringe


hypromellose 2 % per 1 ML Prefilled Syringe

hypromellose 20 MG per 1 ML Prefilled Syringe

hypromellose 2 % in 1 ML Prefilled Syringe

1 ML hypromellose 20 MG/ML Prefilled Syringe


oxyCODONE HCl 5 MG / ibuprofen 400 MG Oral Tablet

ibuprofen 400 MG / oxyCODONE hydrochloride 5 MG Oral Tablet

ibuprofen 400 MG / oxycodone hydrochloride 5 MG Oral Tablet


imatinib (as imatinib mesylate) 400 MG Oral Capsule


donepezil HCl 10 MG Disintegrating Oral Tablet

donepezil hydrochloride 10 MG Disintegrating Oral Tablet


donepezil hydrochloride 1 MG/ML Oral Solution


donepezil HCl 5 MG Disintegrating Oral Tablet

donepezil hydrochloride 5 MG Disintegrating Oral Tablet


DULoxetine 40 MG (as DULoxetine HCl 44.9 MG) Delayed Release Oral Capsule

duloxetine 40 MG (as duloxetine HCl 44.9 MG) Delayed Release Oral Capsule

DULoxetine 40 MG Delayed Release Oral Capsule

duloxetine 40 MG Delayed Release Oral Capsule


eflornithine (as eflornithine hydrochloride) 115 MG/ML Topical Cream


An ethyl ester form of omega-3 fatty acid derived from fish oil, with activity in decreasing serum triglyceride levels. Although its mechanism of action isn't known, omega-3-acid ethyl esters may work by decreasing the amount of triglycerides and other fats made in the liver.


A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.


glatiramer acetate 20 MG in 1 ML Prefilled Syringe

glatiramer acetate 20 MG per 1 ML Prefilled Syringe

1 ML glatiramer acetate 20 MG/ML Prefilled Syringe


Omeprazole 20 MG / NaHCO3 1680 MG Powder for Oral Suspension

omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension


verapamil hydrochloride 180 MG Extended Release Oral Tablet

verapamil HCl 180 MG Extended Release Oral Tablet


insulin detemir 100 UNT/ML Injectable Solution

insulin analog, detemir 100 UNT/ML Injectable Solution


ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT

ipratropium bromide 17 MCG/ACTUAT Metered Dose Inhaler, 200 ACTUAT

ipratropium bromide 17 MCG/INHAL Metered Dose Inhaler, 200 Actuations

200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler


A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.


acetaminophen 160 MG Disintegrating Oral Tablet


lanthanum carbonate 250 MG Chewable Tablet


lanthanum carbonate 500 MG Chewable Tablet


coenzyme Q10 30 MG Chewable Tablet
ubidecarenone 30 MG Chewable Tablet


levofloxacin 25 MG per 1 ML Oral Solution

levofloxacin 250 MG per 10 ML Oral Solution

levoFLOXacin 250 MG per 10 ML Oral Solution

levofloxacin 500 MG per 20 ML Oral Solution

levoFLOXacin 500 MG per 20 ML Oral Solution

levoFLOXacin 25 MG per 1 ML Oral Solution

levoFLOXacin 25 MG in 1 mL Oral Solution


The oil extracted from the fruit peel of Citrus aurantifolia. Lime oil can be taken as an antioxidant and may help support immune health. Additionally, it is used as a flavoring agent.


alpha-tocopherol 3 UNT / ubidecarenone 15 MG Oral Capsule

ubidecarenone 15 MG / vitamin E acetate 3 UNT Oral Capsule

ubidecarenone 15 MG / vitamin E 3 UNT Oral Capsule


clindamycin (as clindamycin phosphate) 1 % Topical Foam


natalizumab 300 MG in 15 ML Injection
natalizumab 300 MG per 15 ML Injection


guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet

guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12 HR Extended Release Oral Tablet

guaifenesin 780 MG / pseudoephedrine HCl 80 MG 12 HR Extended Release Oral Tablet

12 HR guaiFENesin 780 MG / pseudoephedrine hydrochloride 80 MG Extended Release Oral Tablet

12 HR guaifenesin 780 MG / pseudoephedrine hydrochloride 80 MG Extended Release Oral Tablet


polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Solution

polyethylene glycol 400, 0.4 % / propylene glycol 0.3 % Ophthalmic Solution

PEG 400 0.4 % / propylene glycol 0.3 % Ophthalmic Solution


The hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.


aspirin / caffeine / dihydrocodeine Oral Capsule


polyethylene glycol 400 / propylene glycol Ophthalmic Solution


A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin. In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)


erythromycin estolate 250 MG Oral Capsule


3 ML insulin aspart, human 100 UNT/ML Cartridge

insulin, aspart, human 100 UNT/ML per 3 ML Cartridge

insulin aspart 100 UNT/ML in 3 ML Cartridge


erythromycin estolate 500 MG Oral Tablet


A humanized monoclonal antibody directed against terminal complement protein C5. Eculizumab binds to terminal complement protein C5, thereby blocking C5 cleavage into pro-inflammatory components and blocking the complement-mediated destruction of paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. (NCI05)


bromfenac 0.9 MG/ML (bromfenac sodium 1.035 MG/ML) Ophthalmic Solution


clarithromycin 1000 MG Extended Release Oral Tablet


doxycycline 75 MG Disintegrating Oral Tablet


factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection

factor VIII / von Willebrand Factor complex, human 1 UNT Injection

antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection


olopatadine 2 MG/ML (as olopatadine HCl 2.22 MG/ML) Ophthalmic Solution

olopatadine HCl 0.2 % Ophthalmic Solution


DULoxetine 60 MG (as DULoxetine HCl 67.3 MG) Delayed Release Oral Capsule

duloxetine 60 MG Delayed Release Oral Capsule

duloxetine 60 MG (as duloxetine HCl 67.3 MG) Delayed Release Oral Capsule

DULoxetine 60 MG Delayed Release Oral Capsule


human vaccinia immune globulin 50 MG/ML Injectable Solution


emtricitabine 10 MG per 1 ML Oral Solution

emtricitabine 10 MG in 1 mL Oral Solution


prussian blue insoluble 500 MG Oral Capsule


cyanocobalamin 500 MCG/ACTUAT Nasal Spray


alpha 1-proteinase inhibitor, human 1 MG Injection


brimonidine tartrate 0.2 % / timolol maleate 0.5 % Ophthalmic Solution

brimonidine tartrate 0.2 % / timolol 0.5 % Ophthalmic Solution

brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution


drospirenone 2 MG / ethinyl estradiol 1 MG Oral Tablet


DULoxetine 30 MG (as DULoxetine HCl 33.7 MG) Delayed Release Oral Capsule

DULoxetine 30 MG Delayed Release Oral Capsule

duloxetine 30 MG Delayed Release Oral Capsule

duloxetine 30 MG (as duloxetine HCl 33.7 MG) Delayed Release Oral Capsule


fosamprenavir 50 MG per 1 ML Oral Suspension

fosamprenavir 50 MG in 1 mL Oral Suspension

fosamprenavir (as fosamprenavir calcium) 50 MG/ML (amprenavir 43 MG/ML) Oral Suspension


A synthetic melatonin analogue with hypnotic and circadian rhythm-modulating activities. Ramelteon binds to and activates melatonin receptors 1 and 2 in the suprachiasmatic nucleus (SCN) of the brain, thereby promoting the onset of sleep. Unlike the nonbenzodiazepine sedative hypnotics zolpidem and zaleplon, this agent does not activate GABA receptors and, so, produces no GABA receptor-mediated anxiolytic, myorelaxant, and amnesic effects.


An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis.


A second-generation, recombinant humanized IgG1 kappa monoclonal antibody fragment directed against human vascular endothelial growth factor (VEGF) alpha. Ranibizumab binds to VEGF alpha and inhibits VEGF alpha binding to its receptors, VEGFR1 and VEGFR2, thereby preventing the growth and maintenance of tumor blood vessels. The molecular weight of this agent (48 kD) is much smaller than the molecular weight of bevacizumab (MW ~149 kD), allowing complete penetration of the retina and the subretinal space following intravitreal injection. In contrast to other anti-VEGF aptamers such as pegaptanib, ranibizumab has a high specificity and affinity for all soluble human isoforms of VEGF.


A second-generation non-nucleoside reverse transcriptase inhibitor. Rilpivirine is a diarylpyrimidine.


A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.


A partial agonist of the nicotinic acetylcholine receptor (nAChR) subtype alpha4beta2. Nicotine stimulation of central alpha4beta2 nAChRs located at presynaptic terminals in the nucleus accumbens causes the release of the neurotransmitter dopamine, which may be associated with the experience of pleasure; nicotine addiction constitutes a physiologic dependence related to this dopaminergic reward system. As an AChR partial agonist, varenicline attenuates the craving and withdrawal symptoms that occur with abstinence from nicotine but is not habit-forming itself.


Insulin-like growth factor II (180 aa, ~20 kDa) is encoded by the human IGF2 gene. This protein plays a role in cellular growth, development, and mitogenesis.


A cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolite is excreted mainly via the urine.


A lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.


12 HR bupropion hydrochloride 100 MG Extended Release Oral Tablet

buPROPion HCl 100 MG 12HR Extended Release Oral Tablet

buPROPion HCl 100 MG 12 HR Extended Release Oral Tablet

12 HR buPROPion hydrochloride 100 MG Extended Release Oral Tablet

bupropion HCl 100 MG 12 HR Extended Release Oral Tablet


{7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Velivet 28 Day]


{84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Seasonale 91 Day]


{21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Kariva 28 Day]


{21 (memantine hydrochloride 10 MG Oral Tablet) / 28 (memantine hydrochloride 5 MG Oral Tablet) } Pack

memantine HCl 5 MG (28) / 10 MG (21) Tablet Titration Pack


{28 (estrogens, conjugated (USP) 0.3 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.3/1.5 28 Day]

{28 (estrogens, conjugated (USP) 0.3 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.3/1.5 28 Day]


{28 (estrogens, conjugated (USP) 0.45 MG / medroxyPROGESTERone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.45/1.5 28 Day]

{28 (estrogens, conjugated (USP) 0.45 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.45/1.5 28 Day]


mycophenolic acid 180 MG Delayed Release Oral Tablet

mycophenolic acid (as mycophenolate sodium) 180 MG Delayed Release Oral Tablet


mycophenolic acid (as mycophenolate sodium) 360 MG Delayed Release Oral Tablet

mycophenolic acid 360 MG Delayed Release Oral Tablet


darbopoetin alfa 25 MCG in 0.42 ML Prefilled Syringe

0.42 ML darbepoetin alfa 0.06 MG/ML Prefilled Syringe

darbopoetin alfa 25 MCG per 0.42 ML Prefilled Syringe


cetuximab 100 MG in 50 ML Injection
cetuximab 100 MG per 50 ML Injection


Pegasys 180 MCG in 0.5 ML Prefilled Syringe

0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys]

0.5 ML Pegasys 0.36 MG/ML Prefilled Syringe

Pegasys 180 MCG per 0.5 ML Prefilled Syringe


aluminum chloride 12.5 % Topical Solution

aluminum chloride 125 MG/ML Topical Solution


Trichophyton antigen 2 MG/mL Injectable Solution

Trichophyton antigen 2 MG/ML Injectable Solution


pentetate zinc trisodium 1000 MG in 5 ML Injection

pentetate zinc trisodium 1000 MG per 5 ML Injection

5 ML pentetate zinc trisodium 200 MG/ML Injection


dextran 70 0.1 % / glycerin 0.2 % / hypromellose 0.3 % Ophthalmic Solution

dextran 70 1 MG/ML / glycerin 2 MG/ML / hypromellose 3 MG/ML Ophthalmic Solution


phenol 89 % Medicated Pad
phenol 89 % Swab Stick


chondroitin sulfates / glucosamine / methylsulfonylmethane


citric acid 300 MG / sodium citrate 500 MG in 5 mL Oral Solution

citric acid 300 MG / sodium citrate 500 MG per 5 ML Oral Solution

citric acid 60 MG/ML / sodium citrate 100 MG/ML Oral Solution


Lumicain 25 % Topical Solution
lumicain 25 % Topical Solution
Lumicain 250 MG/ML Topical Solution

aluminum chloride 250 MG/ML Topical Solution [Lumicain]


24 HR nitroglycerin 0.6 MG/HR Transdermal System

nitroglycerin 0.6 MG/HR 24HR Transdermal System

nitroglycerin 14 MG/Day 24 HR Transdermal Patch


24 HR nitroglycerin 0.2 MG/HR Transdermal System

nitroglycerin 0.2 MG/HR 24HR Transdermal System

nitroglycerin 5 MG/Day 24 HR Transdermal Patch


24 HR nitroglycerin 0.4 MG/HR Transdermal System

nitroglycerin 0.4 MG/HR 24HR Transdermal System

nitroglycerin 10 MG/Day 24 HR Transdermal Patch


Alora 0.025 MG/Day Twice Weekly Transdermal System

Alora 0.025 MG/Day Twice Weekly Transdermal Patch

84 HR Alora 0.00104 MG/HR Transdermal System

84 HR estradiol 0.00104 MG/HR Transdermal System [Alora]


lanolin 2 % / mineral oil 15 % / petrolatum 83 % Ophthalmic Ointment

lanolin 0.02 MG/MG / mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment


The essential oil extracted from the leaves and flowering tops of Artemisia absinthium. Wormwood oil is toxic but has been used to induce abortions.


stannous fluoride 1.64 % (fluoride ion 1.6 % ) Mouthwash


sodium chloride 0.9 % Irrigation Solution

sodium chloride 0.154 MEQ/ML Irrigation Solution


zinc oxide 0.2 MG/MG Paste [Critic-Aid Skin]


A mouse monoclonal antibody directed against human cluster of differentiation 15 (CD15 or 3-fucosyl-N-acetyllactosamine). Fanolesomab binds to CD15; radioactive labeled fanolesomab may facilitate the visualization of infection sites upon imaging. The CD15 antigen, a carbohydrate adhesion molecule, is expressed on the surface of the majority of granulocytes, including neutrophils and eosinophils and, to a lesser extent, on monocytes. Due to life-threatening side effects, this antibody is no longer on the market.


eleuthero preparation
Siberian ginseng extract


ALPRAZolam 0.25 MG Disintegrating Oral Tablet

alprazolam 0.25 MG Disintegrating Oral Tablet


ALPRAZolam 1 MG Disintegrating Oral Tablet

alprazolam 1 MG Disintegrating Oral Tablet


alprazolam 0.5 MG Disintegrating Oral Tablet

ALPRAZolam 0.5 MG Disintegrating Oral Tablet


ALPRAZolam 2 MG Disintegrating Oral Tablet

alprazolam 2 MG Disintegrating Oral Tablet


24 HR darifenacin 15 MG Extended Release Oral Tablet

darifenacin 15 MG 24HR Extended Release Oral Tablet

darifenacin 15 MG (as darifenacin HBr 17.846 MG) 24 HR Extended Release Oral Tablet


darifenacin 7.5 MG 24HR Extended Release Oral Tablet

darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet

24 HR darifenacin 7.5 MG Extended Release Oral Tablet


HCTZ 25 MG / irbesartan 300 MG Oral Tablet

hydroCHLOROthiazide 25 MG / irbesartan 300 MG Oral Tablet

irbesartan 300 MG / hydroCHLOROthiazide 25 MG Oral Tablet

hydrochlorothiazide 25 MG / irbesartan 300 MG Oral Tablet


fexofenadine hydrochloride 180 MG / pseudoephedrine hydrochloride 240 MG 24 HR Extended Release Oral Tablet

fexofenadine HCl 180 MG / pseudoephedrine HCl 240 MG 24HR Extended Release Oral Tablet

24 HR fexofenadine hydrochloride 180 MG / pseudoephedrine hydrochloride 240 MG Extended Release Oral Tablet


galantamine HBr 24 MG 24HR Extended Release Oral Capsule

24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule

galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule


tiZANidine 6 MG (as tiZANidine HCl 6.87 MG) Oral Capsule

tizanidine 6 MG (as tizanidine HCl 6.87 MG) Oral Capsule


tiZANidine 4 MG (as tiZANidine HCl 4.576 MG) Oral Capsule

tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral Capsule


tiZANidine 2 MG (as tiZANidine HCl 2.288 MG) Oral Capsule

tizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral Capsule


galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule

24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule

galantamine HBr 16 MG 24HR Extended Release Oral Capsule


ARIPiprazole 1 MG per 1 ML Oral Solution

aripiprazole 1 MG per 1 ML Oral Solution


entecavir 0.05 MG per 1 ML Oral Solution


calcium 250 MG / vitamin D2 100 UNT Oral Tablet, as calcium citrate

Calcium Citrate 250 MG / vit-D 100 MG Oral Tablet

calcium citrate 250 MG / vitamin D2 100 UNT Oral Tablet

Calcium Citrate 250 MG / vitamin D 100 MG Oral Tablet

calcium citrate 250 MG / ergocalciferol 100 MG Oral Tablet


benzocaine 5 % / zinc chloride 0.1 % Mucosal Spray

benzocaine 50 MG/ML / zinc chloride 1 MG/ML Mucosal Spray


benzocaine 5 % / zinc chloride 0.1 % Mucous Membrane Topical Solution

benzocaine 50 MG/ML / zinc chloride 1 MG/ML Mucous Membrane Topical Solution


desloratadine 5 MG / pseudoephedrine sulfate 240 MG 24HR Extended Release Oral Tablet

24 HR desloratadine 5 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet


fluocinonide 1 MG per 1 GM Topical Cream


12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 835 MG Extended Release Oral Tablet

dextromethorphan HBr 30 MG / guaiFENesin 835 MG 12 HR Extended Release Oral Tablet

12 HR dextromethorphan hydrobromide 30 MG / guaiFENesin 835 MG Extended Release Oral Tablet

dextromethorphan HBr 30 MG / guaifenesin 835 MG 12 HR Extended Release Oral Tablet

guaiFENesin 835 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet


guaifenesin 1200 MG / phenylephrine HCl 35 MG 12 HR Extended Release Oral Tablet

guaiFENesin 1200 MG / phenylephrine HCl 35 MG 12 HR Extended Release Oral Tablet

guaiFENesin 1200 MG / phenylephrine HCl 35 MG 12HR Extended Release Oral Tablet

12 HR guaiFENesin 1200 MG / phenylephrine hydrochloride 35 MG Extended Release Oral Tablet

12 HR guaifenesin 1200 MG / phenylephrine hydrochloride 35 MG Extended Release Oral Tablet


alpha lipoic acid 50 MG / coenzyme Q10 30 MG / DL-tocopherol 100 UNT Oral Capsule

ubidecarenone 30 MG / thioctic acid 50 MG / tocopherol, dl-alpha 100 MG Oral Capsule

thioctic acid 50 MG / tocopherol,DL-alpha 100 UNT / ubidecarenone 30 MG Oral Capsule


12 HR guaiFENesin 835 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet

12 HR guaifenesin 835 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet

guaiFENesin 835 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet

guaifenesin 835 MG / phenylephrine HCl 25 MG 12 HR Extended Release Oral Tablet

guaiFENesin 835 MG / phenylephrine HCl 25 MG 12HR Extended Release Oral Tablet


galantamine hydrobromide 8 MG 24 HR Extended Release Oral Capsule

24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule

galantamine HBr 8 MG 24HR Extended Release Oral Capsule


alpha-tocopherol 150 UNT / ubidecarenone 100 MG Oral Capsule

ubidecarenone 100 MG / vitamin E acetate 150 UNT Oral Capsule

ubidecarenone 100 MG / vitamin E 150 UNT Oral Capsule


CoQ-10 30 MG / vitamin E acetate 6 UNT Oral Capsule

ubidecarenone 30 MG / vitamin E acetate 6 UNT Oral Capsule

alpha-tocopherol acetate 6 UNT / ubidecarenone 30 MG Oral Capsule


ziconotide 100 MCG in 1 ML Injection
ziconotide 100 MCG per 1 ML Injection

1 ML ziconotide acetate 0.1 MG/ML Injection


ziconotide acetate 500 MCG in 20 ML Injection

ziconotide acetate 500 MCG per 20 ML Injection

20 ML ziconotide acetate 0.025 MG/ML Injection


polysaccharide iron complex Oral Capsule


hyaluronidase, ovine 200 UNT/ML per 1.2 ML Injection

hyaluronidase, ovine 200 UNT/ML in 1.2 ML Injection

1.2 ML hyaluronidase, ovine 200 UNT/ML Injection


The sodium salt form of pegaptanib, a 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti-angiogenic activity. Pegaptanib binds and blocks the activity of the extracellular vascular endothelial growth factor, specifically the 165-amino acid isoform (VEGF165). This prevents VEGF165 from binding to VEGF receptors, thereby blocking angiogenesis as well as preventing VEGF165-induced increases in vessel permeability. VEGF165 is preferentially involved in pathological ocular neovascularisation.


alendronate sodium 70 MG / cholecalciferol 2800 UNT Oral Tablet

alendronic acid 70 MG / vitamin D3 2800 UNT Oral Tablet

alendronic acid 70 MG (as alendronate sodium 91.4 MG) / cholecalciferol 2800 UNT Oral Tablet

alendronic acid 70 MG / cholecalciferol 2800 UNT Oral Tablet


clofarabine 20 MG in 20 ML Injection
clofarabine 20 MG per 20 ML Injection


Lactobacillus acidophilus 500 Million UNT Oral Tablet

Lactobacillus acidophilus 500000000 UNT Oral Tablet


esomeprazole 20 MG (as esomeprazole sodium 21.3 MG) Injection


esomeprazole 40 MG (as esomeprazole sodium 42.5 MG) Injection


pramlintide acetate 0.6 MG/ML Injectable Solution


sodium benzoate 10 % / sodium phenylacetate 10 % in 50 ML Injection

50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection


The tartrate salt form of levalbuterol, the R-enantiomer of the short-acting beta-2 adrenergic receptor agonist albuterol, with bronchodilator activity. Levalbuterol selectively binds to beta-2 adrenergic receptors in bronchial smooth muscle, thereby activating intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, relieve bronchospasms, improve mucociliary clearance and inhibit the release of mediators of immediate hypersensitivity from cells, especially from mast cells.


The sodium salt form of micafungin, a semi-synthetic echinocandin derived from a natural product of the fungus Coleophoma empetri with antifungal activity. Micafungin, like other cyclic lipopeptides, noncompetitively inhibits the fungal specific enzyme 1,3-beta-D-glucan synthase, an enzyme essential for the synthesis of the important fungal cell wall component 1,3-beta-D-glucan. By preventing the synthesis of 1,3-beta-D-glucan, the cell wall is weakened which leads to osmotic lysis and eventually fungal cell death.


ubidecarenone 60 MG / vitamin E acetate 150 UNT Oral Capsule

alpha-tocopherol 150 UNT / ubidecarenone 60 MG Oral Capsule

ubidecarenone 60 MG / vitamin E 150 UNT Oral Capsule


risedronate sodium 30 MG Oral Tablet [Actonel]


risedronate sodium 5 MG Oral Tablet [Actonel]


risedronate sodium 35 MG Oral Tablet [Actonel]


mycophenolic acid Delayed Release Oral Tablet


tiotropium 18 MCG (tiotropium bromide 22.5 MCG) Inhalation Powder


insulin glulisine, human Injectable Solution


darifenacin Extended Release Oral Tablet


benzocaine / zinc chloride Mucosal Spray


benzocaine / zinc chloride Mucous Membrane Topical Solution


cholecalciferol / vitamin A Oral Capsule


carBAMazepine Extended Release Oral Capsule

carbamazepine Extended Release Oral Capsule


citric acid / sodium citrate Oral Solution


aluminum chloride Topical Solution [Lumicain]


estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR [Climara Pro]


A highly purified preparation of ovine testicular hyaluronidase with potential chemoadjuvant activity. Upon subcutaneous administration, hyaluronidase modifies the permeability of connective tissue by hydrolyzing hyaluronic acid. This temporarily decreases interstitial viscosity and allows drugs that are co-injected to spread rapidly through the interstitial space, thereby facilitating absorption and/or distribution of co-injected agents.


magnesium amino acid chelate Oral Tablet


buPROPion Extended Release Oral Tablet [Wellbutrin]

bupropion Extended Release Oral Tablet [Wellbutrin]


NIFEdipine Extended Release Oral Tablet [Adalat]

nifedipine Extended Release Oral Tablet [Adalat]


dilTIAZem Extended Release Oral Capsule [Cartia]

diltiazem Extended Release Oral Capsule [Cartia]


tolterodine Extended Release Oral Capsule [Detrol]


calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG [Pepcid Complete]


naproxen sodium 220 MG (as naproxen 200 MG) Oral Capsule


NIFEdipine Extended Release Oral Tablet [Procardia]

nifedipine Extended Release Oral Tablet [Procardia]


propranolol Extended Release Oral Capsule [Inderal]


diclofenac Extended Release Oral Tablet [Voltaren]


ascorbic acid / iron carbonyl Oral Tablet


hyoscyamine Extended Release Oral Capsule


hydrocortisone / pramoxine Topical Ointment


docusate / ferrous fumarate Extended Release Oral Tablet


chloroxylenol / hydrocortisone / pramoxine Otic Solution


calcium carbonate / prasterone Oral Tablet


hydrocortisone / pramoxine Rectal Suppository


benzyl alcohol / pramoxine Topical Spray


hydrocortisone / pramoxine Topical Cream


hydrocortisone / pramoxine Topical Lotion


neomycin / polymyxin B / pramoxine Topical Cream


chloroxylenol / hydrocortisone / pramoxine Topical Lotion


hyoscyamine Extended Release Oral Tablet


diphenhydrAMINE / pramoxine Topical Lotion

diphenhydramine / pramoxine Topical Lotion


levonordefrin / mepivacaine Injectable Solution


Trichophyton antigen Injectable Solution


follitropin alfa Injectable Solution [Gonal F]


methylPREDNISolone Injectable Solution [SOLU-Medrol]

methylprednisolone Injectable Solution [Solu-Medrol]


rabeprazole sodium 20 MG Delayed Release Oral Tablet [Aciphex]

Aciphex 20 MG Delayed Release Oral Tablet

RABEprazole sodium 20 MG Delayed Release Oral Tablet [Aciphex]

AcipHex 20 MG Delayed Release Oral Tablet


bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment [Lanabiotic]


promethazine Rectal Suppository [Phenergan]


amylase / lipase / protease Oral Capsule


Japanese encephalitis virus vaccine, inactivated


The monohydrate bromide salt form of tiotropium, a quaternary ammonium derivative of atropine and a long-acting muscarinic receptor antagonist, with bronchodilating activity. Upon inhalation, tiotropium binds to and blocks mainly muscarinic M3 receptors located on smooth muscle cells, thereby preventing smooth muscle contraction.


ACT Fluoride Rinse 0.05 % (as fluoride ion 0.02 % ) Mouthwash

ACT 0.05 % (fluoride ion 0.02 % ) Mouthwash

sodium fluoride 0.5 MG/ML Mouthwash [ACT Fluoride Rinse]


sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD]


sodium fluoride 0.011 MG/MG Toothpaste [Denta 5000 Plus]


Prevident 0.011 MG/MG Toothpaste
PreviDent 5000 Plus 1.1 % Toothpaste
PreviDent 1.1 % Toothpaste
PreviDent 5000 Booster 1.1 % Oral Gel

sodium fluoride 0.011 MG/MG Toothpaste [Prevident]


vitamin C 75 MG / ferrous fumarate 333 MG / folate 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule [Ferocon]

Ferocon (ascorbic acid 75 MG / cyanocobalamin 0.015 MG / ferrous fumarate 333 MG / folic acid 0.5 MG / liver stomach concentrate 240 MG) Oral Capsule

vit-C 75 MG / ferrous fumarate 333 MG / folate 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule [Ferocon]

ascorbic acid 75 MG / ferrous fumarate 333 MG / folic acid 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule [Ferocon]


white faced hornet venom protein 0.1 MG/ML Injectable Solution

Dolichovespula maculata venom protein 120 MCG per 1.2 ML Powder for Injectable Solution

bald-faced hornet venom protein 100 MCG/ML Injectable Solution

bald-faced hornet venom protein 0.1 MG/mL Injectable Solution

bald-faced hornet venom protein 0.1 MG/ML Injectable Solution


Dolichovespula arenaria venom protein 100 MCG per ML Powder for Injectable Solution

yellow hornet venom protein 0.1 MG/mL Injectable Solution

Dolichovespula arenaria venom protein 120 MCG per 1.2 ML Powder for Injectable Solution

yellow hornet venom protein 0.1 MG/ML Injectable Solution


benzalkonium Cl 0.1 % / benzocaine 18 % Mucous Membrane Topical Solution

benzalkonium chloride 1 MG/ML / benzocaine 180 MG/ML Mucous Membrane Topical Solution


western honey bee venom protein 0.1 MG/ML Injectable Solution

Apis mellifera venom protein 100 MCG/ML Injectable Solution

European honey bee venom protein 0.1 MG/ML Injectable Solution

European honey bee venom protein 0.1 MG/mL Injectable Solution


Ferrex 150 Forte (cyanocobalamin 0.025 MG / folic acid 1 MG / polysaccharide iron complex 150 MG) Oral Capsule

folate 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule [Ferrex 150 Forte]

Ferrex-150 Forte 150 MG / 25 MCG / 1 MG Oral Capsule

folic acid 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule [Ferrex 150 Forte]